A double-blind, randomized, clinical trial on the antileishmanial activity of a Morinda citrifolia (noni) stem extract and its major constituents

19Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A controlled study was conducted to determine the efficiency of a topical ointment prepared from the stem extract of Morinda citrifolia against cutaneous leishmaniasis. Similarly, the in vitro antileishmanial activity of morindicone and morinthone isolated from the extract were investigated against Leishmania major. These compounds displayed good activity. Out of 40 patients, 50% showed an excellent response and 30% exhibited good improvement.

Cite

CITATION STYLE

APA

Sattar, F. A., Ahmed, F., Ahmed, N., Sattar, S. A., Malghani, M. A. K., & Choudhary, M. I. (2012). A double-blind, randomized, clinical trial on the antileishmanial activity of a Morinda citrifolia (noni) stem extract and its major constituents. Natural Product Communications, 7(2), 195–196. https://doi.org/10.1177/1934578x1200700218

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free